Psoriatic Alopecia And Paradoxical Psoriasis Induced By Adalimumab Successfully Treated With Certolizumab: Clinical, Trichoscopic, And In Vivo Reflectance Confocal Microscopy Features

    December 2022 in “ Skin Appendage Disorders
    Matteo Megna, Mario De Lucia, Lucia Gallo, Wanda Lauro, Vincenzo Picone, Gabriella Fabbrocini, Sonia Sofìa Ocampo‐Garza
    Certolizumab was found to be an effective and safe alternative for managing psoriasis and psoriatic arthritis (PsA), particularly in minimizing the risk of paradoxical reactions such as psoriatic alopecia, compared to other anti-TNF-α agents like adalimumab.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results